European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): Study protocol for a randomized controlled, non-inferiority trial in eight European countries

Trials

Volumn 17, Issue 1, 2016, Pages

  Kleiboer, Annet ^a   Smit, Jan ^b   Bosmans, Judith ^a   Ruwaard, Jeroen ^a   Andersson, Gerhard ^c,d   Topooco, Naira ^c   Berger, Thomas ^e   Krieger, Tobias ^e   Botella, Cristina ^f,g   Baños, Rosa ^g   Chevreul, Karine ^h   Araya, Ricardo ⁱ   Cerga Pashoja, Arlinda ⁱ   Cieślak, Roman ^j   Rogala, Anna ^j   Vis, Christiaan ^a   Draisma, Stasja ^b   Schaik, Anneke ^b   Kemmeren, Lise ^b   Ebert, David ^k   Berking, Matthias ^k   Funk, Burkhardt ^l   Cuijpers, Pim ^a   Riper, Heleen ^a,b   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LINKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITAT JAUME I   (Spain)

^g Evaluación y Tratamiento Psicológicos   (Spain)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j SWPS UNIVERSITY OF SOCIAL SCIENCES AND HUMANITIES   (Poland)

^k PHILIPPS UNIVERSITY MARBURG   (Germany)

^l LEUPHANA UNIVERSITY OF LÜNEBURG   (Germany)

more..

Author keywords

Adults; Blended treatment; Cognitive behavioral treatment (CBT); Comparative effectiveness research (CER); Cost effectiveness; Depression; EHealth; ICBT; Internet based treatment; Randomized controlled trial (RCT)

Indexed keywords

ADULT; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; FRANCE; GERMANY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL HEALTH CARE; NETHERLANDS; PATIENT HEALTH QUESTIONNAIRE 9; POLAND; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SPAIN; SWEDEN; SWITZERLAND; UNITED KINGDOM; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED THERAPY; COST BENEFIT ANALYSIS; ECONOMICS; EUROPE; HEALTH CARE COST; METHODOLOGY; MULTICENTER STUDY; PRIMARY HEALTH CARE; PSYCHOLOGY; QUESTIONNAIRE; TIME FACTOR; TREATMENT OUTCOME;

CLINICAL PROTOCOLS; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; EUROPE; HEALTH CARE COSTS; HUMANS; INTERNET; PRIMARY HEALTH CARE; REMISSION INDUCTION; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES; THERAPY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84982728778     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1511-1     Document Type: Article

References (50)

1. Richards D. Prevalence and clinical course of depression: a review. Clin Psychol Rev. 2011. doi: 10.1016/j.cpr.2011.07.004.
2. Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx B. Is excess mortality in depression generic or specific? A comprehensive meta-analysis of community and patient studies. Am J Psychiatry. 2014. doi: 10.1176/appi.ajp.2013.13030325.
3. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19(1):155-62.
4. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ. 2006;9:193-200.
5. Gustavsson A, Svensson M, Jacobi F, et al. Costs of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718-79.
6. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87-98.
7. Evans-Lacko S, Knapp M. Importance of social and cultural factors for attitudes, disclosure and time off work for depression: findings from a seven country European study on depression in the workplace. PLoS One. 2014;9, e91053. doi: 10.1371/journal.pone.0091053.
8. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioral therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58:376-85.
9. Cuijpers P, van Straten A, van Oppen P, Andersson G. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychol. 2008;69(11):1675-85.
10. Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Andersson G. Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev. 2010;30:51-62.
11. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26:279-88.
12. NICE. The treatment and management of depression in adults. London: National Institute for Clinical Excellence; 2009.
13. Woelbert E. Psychotherapy for mental illness in Europe: an exploration of the evidence base and status quo. European Commission Joint Research Centre; 2015.
14. Andrews G, Issakidis C, Carter G. Shortfall in mental health service utilisation. Br J Psychiatry. 2001;179:417-25. doi: 10.1192/bjp.179.5.417.
15. Spijker J, Bijl RV, De Graaf R, Nolen WA. Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand. 2001;104:19-24. doi: 10.1034/j.1600-0447.2001.00363.x.
16. Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6:21-37.
17. Richards D, Richardson T. Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev. 2012;32(4):329e342.
18. Andersson G, Topooco N, Havik OE, Nordgreen T. Internet-supported versus face-to-face cognitive behavior therapy for depression. Expert Rev Neurother. 2016;16:55-60.
19. Wykes T, Haro JM, Belli SR, Obradors-Tarragó C, Arango C, Ayuso-Mateos JL, Bitter I, Brunn M, Chevreul K, Demotes-Mainard J, Elfeddali I, Evans-Lacko S, Fiorillo A, Forsman AK, Hazo JB, Kuepper R, Knappe S, Leboyer M, McDaid D, Miret M, Papp S, Park AL, Schumann G, Thornicroft G, Feltz-Cornelis CM, van Os J, Wahlbeck K, Walker-Tilley T, Wittchen HU. Mental health research priorities for Europe. Lancet Psychiatry. 2015;2(22):1036-42.
20. Kooistra L, Wiersma JE, Ruwaard J, van Oppen P, Smit F, Lokkerbol J, Cuijpers P, Riper H. Blended vs. face-to-face cognitive behavioural treatment for major depression in specialized mental health care: study protocol of a randomized controlled cost-effectiveness trial. BMC Psychiatry. 2014;14:290.
21. Krieger T, Meyer B, Sude K, Urech A, Maercker A, Berger T. Evaluating an e-mental health program ("deprexis") as adjunctive treatment tool in psychotherapy for depression: design of a pragmatic randomized controlled trial. BMC Psychiatry. 2014;14(1):285.
22. López del Hoyo Y, Olivan B, Luciano JV, Mayoral F, Roca M, Gili M, Andres E, Serrano A, Collazo F, Araya R, Baños RM, Botella C, Magallón R, y García-Campayo J. Low intensity vs. self-guided Internet-delivered psychotherapy for major depression: a multicenter, controlled, randomized study. BMC Psychiatry. 2013;13(21). doi: 10.1186/1471-244X-13-21.
23. Wentzel J, van der Vaart R, Bohlmeijer ET, van Gemert-Pijnen JE. Mixing online and face-to-face therapy: how to benefit from blended care in mental health care. JMIR Mental Health. 2016;3(1), e9.
24. Beattie A, Shaw A, Kaur S, Kessler D. Primary-care patients' expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study. Health Expect. 2009;12:45-59.
25. Montero-Marín J, Carrasco JM, Roca M, Serrano-Blanco A, Gili M, Mayoral F, Luciano JV, Lopez-del-Hoyo Y, Olivan B, Collazo F, Araya R, Baños RM, Botella C, García-Campayo J. Expectations, experiences, and attitudes of patients and primary care health professionals regarding online psychotherapeutic interventions for depression: protocol for a qualitative study. BMC Psychiatry. 2013;13:64.
26. van der Vaart R, Witting M, Riper H, Kooistra L, Bohlmeijer ET, van Gemert-Pijnen L. Blending online therapy into regular face-to-face therapy for depression: content, ratio and preconditions according to patients and therapists using a Delphi study. BMC Psychiatry. 2014;14:355.
27. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials. 2011;12:106. doi: 10.1186/1745-6215-12-106.
28. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346, e7586.
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-13.
31. Cuijpers P, Turner EH, Koole SL, van Dijke A, Smit F. What is the threshold for a clinically relevant effect? The case of major depressive disorders. Depress Anxiety. 2014;31:374-8.
32. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22:1596-602.
33. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of The Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007;29:388-95.
34. Löwe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care. 2004;42:1194-201.
35. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573-83.
36. Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, Dunbar GC. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry. 1997;12:224-31.
37. Group EQ. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
38. van Agt HME, Essink-Bot ML, Krabbe PFM, Bonsel GJ. Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 1994;39:1537-44.
39. Hakkaart-van Rooijen L, van Straten A, Donker M, Tiemans B. Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P). Rotterdam: Institute for Medical Technology Assessment; 2002.
40. Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the working alliance inventory. Psychother Res. 2007;16:12-25.
41. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31:73-86.
42. Nguyen TD, Attkinson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983;6:299-314.
43. Brooke J. SUS-a quick and dirty usability scale. In: Jordan PW, Thomas B, Weerdmeester BA, McClelland IL, editors. Usability Eval Ind. Volume 189. London: Taylor & Francis Ltd; 1996. p. 189-94.
44. Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Hum Comput Interact. 2008;24:574-94.
45. Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ. 2004;13(5):461-75.
46. Black WC. The CE, plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990;10(3):212-4.
47. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 2004;13:405-15.
48. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.
49. Food Drug Administration (FDA). International conference on harmonization, good clinical practice: consolidated guidelines. Fed Regist. 1997;62:25692-709.
50. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.